Cancer remains a significant global health challenge, with chronic inflammation often driving in tumor development and progression. , As a result, the search for novel anti-inflammatory agents to complement conventional cancer therapies is vital. Triiptolide, a synthetic derivative of the natural product triptolide, has emerged as a promising candi

Barzolvolimab: A Promising Possibility for Autoimmune Ailments? Barzolvolimab, a relatively discovered biological molecule, is sparking substantial excitement within the scientific field. This unique protein functions as a effective inhibitor of immune 17F, a crucial mediator in the development of various chronic conditions, including IBD. Prelimi